Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models

Mucinous peritoneal metastases (PM) generally respond poorly to systemic treatment, and there is a clear unmet need for new treatment strategies to improve survival and quality of life for patients with PM. In this work, the growth inhibitory effect of five drugs (oxaliplatin (OXA; 5 mg/kg), irinote...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Oncol
Glavni autori: Fleten, Karianne Giller, Lund-Andersen, Christin, Waagene, Stein, Abrahamsen, Torveig Weum, Mørch, Yrr, Boye, Kjetil, Torgunrud, Annette, Flatmark, Kjersti
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press 2020
Teme:
Original article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243185/
https://ncbi.nlm.nih.gov/pubmed/32447231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100793
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items